Anhui Fengyuan Pharmaceutical (000153.SZ): Peramivir Injection Obtained Drug Registration Certificate

Anhui Fengyuan Pharmaceutical (000153.SZ) announced that recently, the company received the "Drug Registration Certificate" for Peramivir Injection approved and issued by the National Medical Products Administration. The drug is used for the treatment of influenza A or influenza B. Obtaining the registration certificate will enrich the company's product line, optimize its product structure, and help enhance the company's market competitiveness.